Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres

BACKGROUND: The efficacy of adjuvant chemotherapy with fec-d (5-fluorouracil–epirubicin–cyclophosphamide followed by docetaxel) is superior to that with fec-100 alone in women with early-stage breast cancer. As the use of fec-d increased in clinical practice, health care providers anecdotally noted...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Madarnas, Y., Dent, S.F., Husain, S.F., Robinson, A., Alkhayyat, S., Hopman, W.M., Verreault, J.L., Vandenberg, T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Multimed Inc. 2011
Soggetti:
Medical Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108865/
https://ncbi.nlm.nih.gov/pubmed/21655158
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi